Asia Pacific Biopsy Devices Market

Market Overview:

The Asia Pacific biopsy devices market is expected to exhibit moderate growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor. 

Biopsy devices are surgical equipment used to remove tissues from different organs. They are utilized by medical practitioners, surgeons, cardiologists, and radiologists to diagnose the presence of cancerous diseases. Some of the commonly used biopsy devices include aspiration needles, localization wires, and forceps. At present, biopsy devices are employed in medical clinics, hospitals, and diagnostic centers across the Asia Pacific region.

The increasing prevalence of cancer, along with rising initiatives for generating awareness about cancer screening programs, represents one of the significant factors driving the biopsy devices market in the Asia Pacific region. Moreover, the growing risks of infection due to improper care of invasive biopsy wounds have resulted in the introduction of stringent healthcare guidelines, which has further strengthened the market growth. Apart from this, rapid urbanization, in confluence with increasing technological advancements, is creating a positive impact on the market. However, the sudden outbreak of the coronavirus disease (COVID-19) has negatively affected the biopsy devices market as the focus of the healthcare personnel has presently shifted towards the treatment of COVID-19 patients. The market is projected to experience growth once the pandemic situation comes under control.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the Asia Pacific biopsy devices market, along with forecasts at the regional and country level from 2021-2026. Our report has categorized the market based on procedure type, product, application, guidance technique and end user.

Breakup by Procedure Type:

• Surgical Biopsy
• Needle Biopsy
   

Breakup by Product:

• Biopsy Guidance Systems
• Needle Based Biopsy Guns
• Biopsy Needles
• Biopsy Forceps
• Others
   

Breakup by Application:

• Breast Biopsy
• Lung Biopsy
• Colorectal Biopsy
• Prostate Biopsy
• Others
   

Breakup by Guidance Technique:

• Ultrasound-guided Biopsy
• Stereotactic-guided Biopsy
• MRI-guided Biopsy
• Others
   

Breakup by End User:

• Hospitals and Clinics
• Academic and Research Institutes
• Others
   

Breakup by Country:

• China
• Japan
• India
• South Korea
• Australia
• Indonesia
• Others
   

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Report Coverage:

Key Questions Answered in This Report:

• How has the Asia Pacific biopsy devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Asia Pacific biopsy devices market?
• What are the key regional markets?
• What is the breakup of the market based on the procedure type?
• What is the breakup of the market based on the product?
• What is the breakup of the market based on the application?
• What is the breakup of the market based on the guidance technique?
• What is the breakup of the market based on the end user?
• What are the various stages in the value chain of the industry?
• What are the key driving factors and challenges in the industry?
• What is the structure of the Asia Pacific biopsy devices market and who are the key players?
• What is the degree of competition in the industry?